跳至主要内容
临床试验/ACTRN12616000519459
ACTRN12616000519459尚未招募未知

Assessing Predictive and Prognostic Biomarkers in Pancreatic Cancer

The Walter and Eliza Hall Institute of Medical Research0 个研究点目标入组 500 人开始时间: 2016年4月21日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Male and female
  • 2. At least 18 years of age
  • 3. Patients with histologically or cytologically confirmed pancreatic cancer.
  • 4. Able to provide archival tumour specimen for molecular analysis
  • 5. Accessible for follow up and data collection
  • 6. Able and willing to provide informed consent for any blood and urine collection above standard of care. Able to provide written, voluntary and informed consent for blood and/or urine collection

排除标准

  • 1. No archival tissue specimen available for molecular analysis
  • 2. Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the tissue collection protocol
  • 3. Females who are pregnant

研究者

相似试验

Biomarkers in Pancreatic Cancer | 临床试验